z-logo
open-access-imgOpen Access
Screening for Mutations Related to Atovaquone/Proguanil Resistance in Treatment Failures and Other Imported Isolates ofPlasmodium falciparumin Europe
Author(s) -
Ole Wichmann,
Nikolai Muehlberger,
Tomáš Jelı́nek,
Michael Alifrangis,
Gabriele PeyerlHoffmann,
Marion Mühlen,
Martin P. Grobusch,
Joaquím Gascón,
Alberto Matteelli,
Hermann Laferl,
Zeno Bisoffi,
Stephan Ehrhardt,
Juan CuadrosGonzález,
Christoph Hatz,
Ida Gjørup,
Paul McWhinney,
Jiřı́ Beran,
Saraiva da Cunha,
Marco H. Schulze,
Herwig Kollaritsch,
Peter Kern,
Graham Fry,
Joachim Richter
Publication year - 2004
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/424469
Subject(s) - atovaquone , proguanil , plasmodium falciparum , medicine , point mutation , virology , biology , genetics , malaria , mutation , gene , immunology
Two single-point mutations of the Plasmodium falciparum cytochrome b gene (Tyr268Asn and Tyr268Ser) were recently reported in cases of atovaquone/proguanil (Malarone) treatment failure. However, little is known about the prevalence of codon-268 mutations and their quantitative association with treatment failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom